The Trulicity pen -- an injectable drug for patients to manage their type 2 diabetes -- has been around for quite some time.

Medically reviewed by Lindsay Cook, PharmD Trulicity (dulaglutide) and Ozempic (semaglutide) are medications used to manage high blood sugar levels associated with type 2 diabetes. They are classified ...

Meanwhile, Lilly also confirmed that it will start running a head-to-head cardiovascular outcomes trial for Trulicity and one of its pipeline diabetes candidates – dual GIP/GLP1 agonist tirzepat ...

Trulicity is another type of GLP-1 receptor agonist that is effective for reducing blood sugar levels and heart disease risk in people with diabetes. Like Ozempic, it’s an injectable medication ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

Trulicity is a GLP-1 agonist that helps manage type 2 diabetes and has shown to aid in weight loss. Clinical trials showed that Trulicity helped reduce A1C levels by 1.5% to 1.9% over 24 weeks.

The company is also known for drugs to treat diabetes (Trulicity, Humalog) and depression (Prozac, Cymbalta).

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

Meanwhile, Lilly also confirmed that it will start running a head-to-head cardiovascular outcomes trial for Trulicity and one of its pipeline diabetes candidates – dual GIP/GLP1 agonist tirzepat ...